Substance-Related Disorders
324
22
31
254
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
53 trials with published results (16%)
Research Maturity
254 completed trials (78% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.2%
7 terminated out of 324 trials
97.3%
+10.8% vs benchmark
15%
47 trials in Phase 3/4
21%
53 of 254 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 254 completed trials
Clinical Trials (324)
We The Village Family Support Study
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
Preventing Impaired Driving Among Adolescents
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
Mobile Technologies Extending Reach of Primary Care for Substance Use Disorders
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
Validation of the Behavioral Activation for Depression Scale in Individuals With Substance Use Disorders
Fatal Overdose Review Teams - Research to Enhance Surveillance Systems
Reducing Drug Use in Justice-Involved Emerging Adults
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
Women's Treatment and Early Recovery
Alcohol, Psychoactive Drugs, Analgesics and Evaluation in Penetrating Abdominal Trauma
Whole Health in VA Mental Health: Omnis Salutis
Maternal Brain Imaging in Opioid Use Disorder
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Prevention of Relapse in Behavioral Disorders
Understanding the Role of Doulas in Supporting People With PMADs